Abbott Laboratories
XETRA:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Abbott Laboratories (ABL) under the Base Case is EUR per share.
Compared with the current market price of 98.86 EUR, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Abbott Laboratories Does
Abbott Laboratories is a healthcare company that makes products doctors, hospitals, and patients use every day. Its business is built around four main areas: medical devices, diagnostic tests, nutrition products, and established medicines in international markets. In simple terms, Abbott sells tools to monitor health, tests to find disease, food and nutrition products for infants and adults, and selected brand-name medicines outside the United States.
- Headquarters
- United States of America US
- Employees
- 115 000
- IPO date
- Mar 1, 1937
Abbott Laboratories has a narrow economic moat
Patents and medical approvals make Abbott’s protected devices difficult to copy and bring to market. Laboratories that build their testing around Abbott equipment also face work and disruption when changing suppliers, helping Abbott retain repeat purchases. These protections are strongest in particular products rather than across everything Abbott sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Abbott Laboratories
Earnings Waterfall
Abbott Laboratories
What is the Intrinsic Value of one ABL stock?
The intrinsic value for Abbott Laboratories (ABL) under the Base Case is EUR.
Is ABL stock undervalued or overvalued?
Compared with the current market price of 98.86 EUR, the stock appears .
